ZELLUNA ASA
Pioneering TCR-NK cell therapies to eliminate solid cancers effectively.
Översikt
- 8
- Anställda
- Okänt
- Omsättning
- 2011
- Grundat
Nyckelbeslutsfattare
Namir Hassan
Chief Executive Officer
Anders Tuv
Managing Director Radforsk Invest
Geir Christian Melen
Chief Financial Officer
Luise Weigand
Chief Scientific Officer
+15 fler kontakter i Funnelfeedr
Beskrivning
Zelluna ASA is a biotechnology company focused on pioneering novel cell therapies for cancer treatment. Their primary mission is to eliminate solid cancers, which represent the largest cancer burden globally. They are developing a unique and proprietary TCR-NK (T cell receptor guided natural killer)...